顶部logo
顶部logo
more_1

home

ホーム > レポート一覧 > 腫瘍遺伝子検査サービスの世界市場規模、シェア、企業ランキング、売上、需要動向予測（2026～2032年）

腫瘍遺伝子検査サービスの世界市場規模、シェア、企業ランキング、売上、需要動向予測（2026～2032年）

Tumor Gene Test Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
  • レポートID：
    278225
  • 発表時期：
    2026-05-13
  • レポート形式：
    PDF
  • 産業カテゴリー：
    ソフト及び商業サービス
  • レポート言語：
    英語、日本語
  • ページ数：
    87
  • 発行会社（調査会社）：
    QYResearch
title

言語とエディションの価格

  • 英語版
  • 日本語版
  • 英語と日本語版

個人版詳細

マルチユーザー版詳細

企業版詳細

  • 英語版
  • 日本語版
  • 英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=159.00円。

※米ドル表示価格+10％消費税。

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

title

レポートの概要

本報告書は、世界の腫瘍遺伝子検査サービス市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。売上高に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点から腫瘍遺伝子検査サービス市場を分析し、需要構造と成長特性を明確化します。
腫瘍遺伝子検査サービス市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、腫瘍遺伝子検査サービスに関する的確な意思決定を行うための実践的なインサイトを提供します。
 主要腫瘍遺伝子検査サービス市場の統計
2025年世界市場規模：百万米ドル
2026年世界市場規模：百万米ドル
2032年予測市場規模：百万米ドル
2026–2032年予測期間CAGR：
本レポートは腫瘍遺伝子検査サービス市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。 
【市場セグメンテーション】
主要企業・競争環境
腫瘍遺伝子検査サービス市場の主要企業には以下が含まれます：
Illumina
BGI Genomics Co.,Ltd.
Agilent Technologies
Macrogen
Pacific Biosciences
10x Genomics
QIAGEN
GEEWIZ
MACROGEN
Oxford Nanopore Technologies 

製品別
Tumor Tissue
Blood 

アプリケーション別
Medical Institution
Scientific Research Institutions
Pharmaceutical Companies
Individual User 

レポート対象地域
北米：アメリカ、カナダ、その他
アジア太平洋：中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ：メキシコ、ブラジル、その他
中東・アフリカ：トルコ、サウジアラビア、UAE、その他
レポート構成（章別概要）
第1章｜市場概要と成長展望
腫瘍遺伝子検査サービス市場の全体像を整理し、市場規模、売上予測を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章｜主要企業の競争分析
腫瘍遺伝子検査サービス市場における主要プレイヤー（トップ5社・トップ10社）を対象に、売上高、製造拠点、製品構成、市場シェアを多面的に分析し、競争構造を明確化します
第3章｜製品カテゴリ別市場動向
製品タイプ別に腫瘍遺伝子検査サービス市場を分類し、売上高、市場シェアを分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章｜用途別市場動向
用途別に腫瘍遺伝子検査サービス市場規模、売上高、市場シェアを整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章｜地域別市場分析
地域別の市場成長率、売上高を詳細に分析し、腫瘍遺伝子検査サービス市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します。
第6章｜国別市場動向
主要国・地域ごとに、腫瘍遺伝子検査サービス市場の売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章｜主要企業プロファイル
腫瘍遺伝子検査サービス市場を牽引する主要企業について、売上高、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章｜バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章｜調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章｜付録（調査手法・データソース）
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します

本レポートの要点と洞察
●腫瘍遺伝子検査サービス市場の全体像と成長見通し
腫瘍遺伝子検査サービス市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境が腫瘍遺伝子検査サービス市場に与える影響を分析いたします。
●市場環境の構成要素とマクロトレンド
腫瘍遺伝子検査サービス産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します。
●競争構造と主要企業の動向分析
腫瘍遺伝子検査サービス市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します。
●競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点から腫瘍遺伝子検査サービス市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします。
●成長要因・課題・リスクの分析
腫瘍遺伝子検査サービス市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します。
●将来トレンドと市場展望
腫瘍遺伝子検査サービス市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします。
title

Description

The global market for Tumor Gene Test Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

The North American market for Tumor Gene Test Service was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Tumor Gene Test Service was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Tumor Gene Test Service was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

The global key companies in the Tumor Gene Test Service market include Illumina、BGI Genomics Co.,Ltd.、Agilent Technologies、Macrogen、Pacific Biosciences、10x Genomics、QIAGEN、GEEWIZ、MACROGEN、Oxford Nanopore Technologies, etc. In 2025, the five largest players accounted for approximately % of revenue.

This report provides a comprehensive view of the global market for Tumor Gene Test Service, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Tumor Gene Test Service market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Tumor Gene Test Service.

Market Segmentation
By Company
    Illumina
    BGI Genomics Co.,Ltd.
    Agilent Technologies
    Macrogen
    Pacific Biosciences
    10x Genomics
    QIAGEN
    GEEWIZ
    MACROGEN
    Oxford Nanopore Technologies

Segment by Type
    Tumor Tissue
    Blood

Segment by Application
    Medical Institution
    Scientific Research Institutions
    Pharmaceutical Companies
    Individual User

Consumption by Region
    North America
        United States
        Canada
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia-Pacific
    Europe
        Germany
        France
        U.K.
        Italy
        Netherlands
        Nordic Countries
        Rest of Europe
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Tumor Gene Test Service companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Tumor Gene Test Service revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Tumor Gene Test Service revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
title

Table of Contents

1 Market Overview
    1.1 Tumor Gene Test Service Product Introduction
    1.2 Global Tumor Gene Test Service Market Size Forecast (2021–2032)
    1.3 Tumor Gene Test Service Market Trends & Drivers
        1.3.1 Tumor Gene Test Service Industry Trends
        1.3.2 Tumor Gene Test Service Market Drivers & Opportunities
        1.3.3 Tumor Gene Test Service Market Challenges
        1.3.4 Tumor Gene Test Service Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered
2 Competitive Analysis by Company
    2.1 Global Tumor Gene Test Service Players Revenue Ranking (2025)
    2.2 Global Tumor Gene Test Service Revenue by Company (2021–2026)
    2.3 Key Companies’ R&D and Operations Footprint and Headquarters
    2.4 Key Companies Tumor Gene Test Service Product Offerings
    2.5 Key Companies General Availability (GA) Timeline for Tumor Gene Test Service
    2.6 Tumor Gene Test Service Market Competitive Analysis
        2.6.1 Tumor Gene Test Service Market Concentration Rate (2021–2026)
        2.6.2 Top 5 and Top 10 Global Companies by Tumor Gene Test Service Revenue in 2025
        2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Tumor Gene Test Service revenue, 2025
    2.7 Mergers & Acquisitions and Expansion
3 Segmentation Tumor Gene Test Service Market Classification
    3.1 Introduction by Type
        3.1.1 Tumor Tissue
        3.1.2 Blood
        3.1.3 Global Tumor Gene Test Service Sales Value by Type
            3.1.3.1 Global Tumor Gene Test Service Sales Value by Type (2021 vs 2025 vs 2032)
            3.1.3.2 Global Tumor Gene Test Service Sales Value, by Type (2021–2032)
            3.1.3.3 Global Tumor Gene Test Service Sales Value, by Type (%), 2021–2032
4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Medical Institution
        4.1.2 Scientific Research Institutions
        4.1.3 Pharmaceutical Companies
        4.1.4 Individual User
    4.2 Global Tumor Gene Test Service Sales Value by Application
        4.2.1 Global Tumor Gene Test Service Sales Value by Application (2021 vs 2025 vs 2032)
        4.2.2 Global Tumor Gene Test Service Sales Value by Application (2021–2032)
        4.2.3 Global Tumor Gene Test Service Sales Value by Application (%), 2021–2032
5 Segmentation by Region
    5.1 Global Tumor Gene Test Service Sales Value by Region
        5.1.1 Global Tumor Gene Test Service Sales Value by Region: 2021 vs 2025 vs 2032
        5.1.2 Global Tumor Gene Test Service Sales Value by Region (2021–2026)
        5.1.3 Global Tumor Gene Test Service Sales Value by Region (2027–2032)
        5.1.4 Global Tumor Gene Test Service Sales Value by Region (%), 2021–2032
    5.2 North America
        5.2.1 North America Tumor Gene Test Service Sales Value, 2021–2032
        5.2.2 North America Tumor Gene Test Service Sales Value by Country (%), 2025 vs 2032
    5.3 Europe
        5.3.1 Europe Tumor Gene Test Service Sales Value, 2021–2032
        5.3.2 Europe Tumor Gene Test Service Sales Value by Country (%), 2025 vs 2032
    5.4 Asia Pacific
        5.4.1 Asia Pacific Tumor Gene Test Service Sales Value, 2021–2032
        5.4.2 Asia Pacific Tumor Gene Test Service Sales Value by Subregion (%), 2025 vs 2032
    5.5 South America
        5.5.1 South America Tumor Gene Test Service Sales Value, 2021–2032
        5.5.2 South America Tumor Gene Test Service Sales Value by Country (%), 2025 vs 2032
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Tumor Gene Test Service Sales Value, 2021–2032
        5.6.2 Middle East & Africa Tumor Gene Test Service Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Tumor Gene Test Service Sales Value Growth Trends, 2021 vs 2025 vs 2032
    6.2 Key Countries/Regions Tumor Gene Test Service Sales Value, 2021–2032
    6.3 United States
        6.3.1 United States Tumor Gene Test Service Sales Value, 2021–2032
        6.3.2 United States Tumor Gene Test Service Sales Value by Type (%), 2025 vs 2032
        6.3.3 United States Tumor Gene Test Service Sales Value by Application, 2025 vs 2032
    6.4 Europe
        6.4.1 Europe Tumor Gene Test Service Sales Value, 2021–2032
        6.4.2 Europe Tumor Gene Test Service Sales Value by Type (%), 2025 vs 2032
        6.4.3 Europe Tumor Gene Test Service Sales Value by Application, 2025 vs 2032
    6.5 China
        6.5.1 China Tumor Gene Test Service Sales Value, 2021–2032
        6.5.2 China Tumor Gene Test Service Sales Value by Type (%), 2025 vs 2032
        6.5.3 China Tumor Gene Test Service Sales Value by Application, 2025 vs 2032
    6.6 Japan
        6.6.1 Japan Tumor Gene Test Service Sales Value, 2021–2032
        6.6.2 Japan Tumor Gene Test Service Sales Value by Type (%), 2025 vs 2032
        6.6.3 Japan Tumor Gene Test Service Sales Value by Application, 2025 vs 2032
    6.7 South Korea
        6.7.1 South Korea Tumor Gene Test Service Sales Value, 2021–2032
        6.7.2 South Korea Tumor Gene Test Service Sales Value by Type (%), 2025 vs 2032
        6.7.3 South Korea Tumor Gene Test Service Sales Value by Application, 2025 vs 2032
    6.8 Southeast Asia
        6.8.1 Southeast Asia Tumor Gene Test Service Sales Value, 2021–2032
        6.8.2 Southeast Asia Tumor Gene Test Service Sales Value by Type (%), 2025 vs 2032
        6.8.3 Southeast Asia Tumor Gene Test Service Sales Value by Application, 2025 vs 2032
    6.9 India
        6.9.1 India Tumor Gene Test Service Sales Value, 2021–2032
        6.9.2 India Tumor Gene Test Service Sales Value by Type (%), 2025 vs 2032
        6.9.3 India Tumor Gene Test Service Sales Value by Application, 2025 vs 2032
7 Company Profiles
    7.1 Illumina
        7.1.1 Illumina Profile
        7.1.2 Illumina Main Business
        7.1.3 Illumina Tumor Gene Test Service Products, Services, and Solutions
        7.1.4 Illumina Tumor Gene Test Service Revenue (US$ Million), 2021–2026
        7.1.5 Illumina Recent Developments
    7.2 BGI Genomics Co.,Ltd.
        7.2.1 BGI Genomics Co.,Ltd. Profile
        7.2.2 BGI Genomics Co.,Ltd. Main Business
        7.2.3 BGI Genomics Co.,Ltd. Tumor Gene Test Service Products, Services, and Solutions
        7.2.4 BGI Genomics Co.,Ltd. Tumor Gene Test Service Revenue (US$ Million), 2021–2026
        7.2.5 BGI Genomics Co.,Ltd. Recent Developments
    7.3 Agilent Technologies
        7.3.1 Agilent Technologies Profile
        7.3.2 Agilent Technologies Main Business
        7.3.3 Agilent Technologies Tumor Gene Test Service Products, Services, and Solutions
        7.3.4 Agilent Technologies Tumor Gene Test Service Revenue (US$ Million), 2021–2026
        7.3.5 Agilent Technologies Recent Developments
    7.4 Macrogen
        7.4.1 Macrogen Profile
        7.4.2 Macrogen Main Business
        7.4.3 Macrogen Tumor Gene Test Service Products, Services, and Solutions
        7.4.4 Macrogen Tumor Gene Test Service Revenue (US$ Million), 2021–2026
        7.4.5 Macrogen Recent Developments
    7.5 Pacific Biosciences
        7.5.1 Pacific Biosciences Profile
        7.5.2 Pacific Biosciences Main Business
        7.5.3 Pacific Biosciences Tumor Gene Test Service Products, Services, and Solutions
        7.5.4 Pacific Biosciences Tumor Gene Test Service Revenue (US$ Million), 2021–2026
        7.5.5 Pacific Biosciences Recent Developments
    7.6 10x Genomics
        7.6.1 10x Genomics Profile
        7.6.2 10x Genomics Main Business
        7.6.3 10x Genomics Tumor Gene Test Service Products, Services, and Solutions
        7.6.4 10x Genomics Tumor Gene Test Service Revenue (US$ Million), 2021–2026
        7.6.5 10x Genomics Recent Developments
    7.7 QIAGEN
        7.7.1 QIAGEN Profile
        7.7.2 QIAGEN Main Business
        7.7.3 QIAGEN Tumor Gene Test Service Products, Services, and Solutions
        7.7.4 QIAGEN Tumor Gene Test Service Revenue (US$ Million), 2021–2026
        7.7.5 QIAGEN Recent Developments
    7.8 GEEWIZ
        7.8.1 GEEWIZ Profile
        7.8.2 GEEWIZ Main Business
        7.8.3 GEEWIZ Tumor Gene Test Service Products, Services, and Solutions
        7.8.4 GEEWIZ Tumor Gene Test Service Revenue (US$ Million), 2021–2026
        7.8.5 GEEWIZ Recent Developments
    7.9 MACROGEN
        7.9.1 MACROGEN Profile
        7.9.2 MACROGEN Main Business
        7.9.3 MACROGEN Tumor Gene Test Service Products, Services, and Solutions
        7.9.4 MACROGEN Tumor Gene Test Service Revenue (US$ Million), 2021–2026
        7.9.5 MACROGEN Recent Developments
    7.10 Oxford Nanopore Technologies
        7.10.1 Oxford Nanopore Technologies Profile
        7.10.2 Oxford Nanopore Technologies Main Business
        7.10.3 Oxford Nanopore Technologies Tumor Gene Test Service Products, Services, and Solutions
        7.10.4 Oxford Nanopore Technologies Tumor Gene Test Service Revenue (US$ Million), 2021–2026
        7.10.5 Oxford Nanopore Technologies Recent Developments
8 Industry Chain Analysis
    8.1 Tumor Gene Test Service Value Chain
    8.2 Tumor Gene Test Service Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Key Suppliers of Raw Materials
        8.2.3 Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream (Customer) Analysis
    8.5 Sales Model and Sales Channelss
        8.5.1 Tumor Gene Test Service Sales Model
        8.5.2 Sales Channels
        8.5.3 Tumor Gene Test Service Distributors
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer
title

Table of Figures

List of Tables
 Table 1. Tumor Gene Test Service Market Trends
 Table 2. Tumor Gene Test Service Market Drivers & Opportunities
 Table 3. Tumor Gene Test Service Market Challenges
 Table 4. Tumor Gene Test Service Market Restraints
 Table 5. Global Tumor Gene Test Service Revenue by Company (US$ Million), 2021–2026
 Table 6. Global Tumor Gene Test Service Revenue Market Share by Company (2021–2026)
 Table 7. Key Companies’ R&D and Operations Footprint and Headquarters
 Table 8. Key Companies Tumor Gene Test Service Product Type
 Table 9. Key Companies General Availability (GA) Timeline for Tumor Gene Test Service
 Table 10. Global Tumor Gene Test Service Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Tumor Gene Test Service revenue, 2025
 Table 12. Mergers & Acquisitions and Expansion Plans
 Table 13. Global Tumor Gene Test Service Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
 Table 14. Global Tumor Gene Test Service Sales Value by Type (US$ Million), 2021–2026
 Table 15. Global Tumor Gene Test Service Sales Value by Type (US$ Million), 2027–2032
 Table 16. Global Tumor Gene Test Service Sales Market Share in Value by Type (2021–2026)
 Table 17. Global Tumor Gene Test Service Sales Market Share in Value by Type (2027–2032)
 Table 18. Global Tumor Gene Test Service Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
 Table 19. Global Tumor Gene Test Service Sales Value by Application (US$ Million), 2021–2026
 Table 20. Global Tumor Gene Test Service Sales Value by Application (US$ Million), 2027–2032
 Table 21. Global Tumor Gene Test Service Sales Market Share in Value by Application (2021–2026)
 Table 22. Global Tumor Gene Test Service Sales Market Share in Value by Application (2027–2032)
 Table 23. Global Tumor Gene Test Service Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
 Table 24. Global Tumor Gene Test Service Sales Value by Region (US$ Million), 2021–2026
 Table 25. Global Tumor Gene Test Service Sales Value by Region (US$ Million), 2027–2032
 Table 26. Global Tumor Gene Test Service Sales Value by Region (%), 2021–2026
 Table 27. Global Tumor Gene Test Service Sales Value by Region (%), 2027–2032
 Table 28. Key Countries/Regions Tumor Gene Test Service Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
 Table 29. Key Countries/Regions Tumor Gene Test Service Sales Value, (US$ Million), 2021–2026
 Table 30. Key Countries/Regions Tumor Gene Test Service Sales Value, (US$ Million), 2027–2032
 Table 31. Illumina Basic Information List
 Table 32. Illumina Description and Business Overview
 Table 33. Illumina Tumor Gene Test Service Products, Services, and Solutions
 Table 34. Revenue (US$ Million) in Tumor Gene Test Service Business of Illumina (2021–2026)
 Table 35. Illumina Recent Developments
 Table 36. BGI Genomics Co.,Ltd. Basic Information List
 Table 37. BGI Genomics Co.,Ltd. Description and Business Overview
 Table 38. BGI Genomics Co.,Ltd. Tumor Gene Test Service Products, Services, and Solutions
 Table 39. Revenue (US$ Million) in Tumor Gene Test Service Business of BGI Genomics Co.,Ltd. (2021–2026)
 Table 40. BGI Genomics Co.,Ltd. Recent Developments
 Table 41. Agilent Technologies Basic Information List
 Table 42. Agilent Technologies Description and Business Overview
 Table 43. Agilent Technologies Tumor Gene Test Service Products, Services, and Solutions
 Table 44. Revenue (US$ Million) in Tumor Gene Test Service Business of Agilent Technologies (2021–2026)
 Table 45. Agilent Technologies Recent Developments
 Table 46. Macrogen Basic Information List
 Table 47. Macrogen Description and Business Overview
 Table 48. Macrogen Tumor Gene Test Service Products, Services, and Solutions
 Table 49. Revenue (US$ Million) in Tumor Gene Test Service Business of Macrogen (2021–2026)
 Table 50. Macrogen Recent Developments
 Table 51. Pacific Biosciences Basic Information List
 Table 52. Pacific Biosciences Description and Business Overview
 Table 53. Pacific Biosciences Tumor Gene Test Service Products, Services, and Solutions
 Table 54. Revenue (US$ Million) in Tumor Gene Test Service Business of Pacific Biosciences (2021–2026)
 Table 55. Pacific Biosciences Recent Developments
 Table 56. 10x Genomics Basic Information List
 Table 57. 10x Genomics Description and Business Overview
 Table 58. 10x Genomics Tumor Gene Test Service Products, Services, and Solutions
 Table 59. Revenue (US$ Million) in Tumor Gene Test Service Business of 10x Genomics (2021–2026)
 Table 60. 10x Genomics Recent Developments
 Table 61. QIAGEN Basic Information List
 Table 62. QIAGEN Description and Business Overview
 Table 63. QIAGEN Tumor Gene Test Service Products, Services, and Solutions
 Table 64. Revenue (US$ Million) in Tumor Gene Test Service Business of QIAGEN (2021–2026)
 Table 65. QIAGEN Recent Developments
 Table 66. GEEWIZ Basic Information List
 Table 67. GEEWIZ Description and Business Overview
 Table 68. GEEWIZ Tumor Gene Test Service Products, Services, and Solutions
 Table 69. Revenue (US$ Million) in Tumor Gene Test Service Business of GEEWIZ (2021–2026)
 Table 70. GEEWIZ Recent Developments
 Table 71. MACROGEN Basic Information List
 Table 72. MACROGEN Description and Business Overview
 Table 73. MACROGEN Tumor Gene Test Service Products, Services, and Solutions
 Table 74. Revenue (US$ Million) in Tumor Gene Test Service Business of MACROGEN (2021–2026)
 Table 75. MACROGEN Recent Developments
 Table 76. Oxford Nanopore Technologies Basic Information List
 Table 77. Oxford Nanopore Technologies Description and Business Overview
 Table 78. Oxford Nanopore Technologies Tumor Gene Test Service Products, Services, and Solutions
 Table 79. Revenue (US$ Million) in Tumor Gene Test Service Business of Oxford Nanopore Technologies (2021–2026)
 Table 80. Oxford Nanopore Technologies Recent Developments
 Table 81. Revenue (US$ Million) in Tumor Gene Test Service Business of Company 40 (2021–2026)
 Table 82. Company 40 Recent Developments
 Table 83. Key Raw Materials Lists
 Table 84. Key Suppliers of Raw Materials Lists
 Table 85. Tumor Gene Test Service Downstream Customers
 Table 86. Tumor Gene Test Service Distributors List
 Table 87. Research Programs/Design for This Report
 Table 88. Key Data Information from Secondary Sources
 Table 89. Key Data Information from Primary Sources


List of Figures
 Figure 1. Tumor Gene Test Service Product Picture
 Figure 2. Global Tumor Gene Test Service Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 3. Global Tumor Gene Test Service Sales Value (US$ Million), 2021–2032
 Figure 4. Tumor Gene Test Service Report Years Considered
 Figure 5. Global Tumor Gene Test Service Players Revenue Ranking (US$ Million), 2025
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Tumor Gene Test Service Revenue in 2025
 Figure 7. Tumor Gene Test Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 8. Tumor Tissue Picture
 Figure 9. Blood Picture
 Figure 10. Global Tumor Gene Test Service Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Tumor Gene Test Service Sales Value Market Share by Type, 2025 & 2032
 Figure 12. Product Picture of Medical Institution
 Figure 13. Product Picture of Scientific Research Institutions
 Figure 14. Product Picture of Pharmaceutical Companies
 Figure 15. Product Picture of Individual User
 Figure 16. Global Tumor Gene Test Service Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Tumor Gene Test Service Sales Value Market Share by Application, 2025 & 2032
 Figure 18. North America Tumor Gene Test Service Sales Value (US$ Million), 2021–2032
 Figure 19. North America Tumor Gene Test Service Sales Value by Country (%), 2025 vs 2032
 Figure 20. Europe Tumor Gene Test Service Sales Value (US$ Million), 2021–2032
 Figure 21. Europe Tumor Gene Test Service Sales Value by Country (%), 2025 vs 2032
 Figure 22. Asia Pacific Tumor Gene Test Service Sales Value (US$ Million), 2021–2032
 Figure 23. Asia Pacific Tumor Gene Test Service Sales Value by Subregion (%), 2025 vs 2032
 Figure 24. South America Tumor Gene Test Service Sales Value (US$ Million), 2021–2032
 Figure 25. South America Tumor Gene Test Service Sales Value by Country (%), 2025 vs 2032
 Figure 26. Middle East & Africa Tumor Gene Test Service Sales Value (US$ Million), 2021–2032
 Figure 27. Middle East & Africa Tumor Gene Test Service Sales Value by Country (%), 2025 vs 2032
 Figure 28. Key Countries/Regions Tumor Gene Test Service Sales Value (%), 2021–2032
 Figure 29. United States Tumor Gene Test Service Sales Value (US$ Million), 2021–2032
 Figure 30. United States Tumor Gene Test Service Sales Value by Type (%), 2025 vs 2032
 Figure 31. United States Tumor Gene Test Service Sales Value by Application (%), 2025 vs 2032
 Figure 32. Europe Tumor Gene Test Service Sales Value (US$ Million), 2021–2032
 Figure 33. Europe Tumor Gene Test Service Sales Value by Type (%), 2025 vs 2032
 Figure 34. Europe Tumor Gene Test Service Sales Value by Application (%), 2025 vs 2032
 Figure 35. China Tumor Gene Test Service Sales Value (US$ Million), 2021–2032
 Figure 36. China Tumor Gene Test Service Sales Value by Type (%), 2025 vs 2032
 Figure 37. China Tumor Gene Test Service Sales Value by Application (%), 2025 vs 2032
 Figure 38. Japan Tumor Gene Test Service Sales Value (US$ Million), 2021–2032
 Figure 39. Japan Tumor Gene Test Service Sales Value by Type (%), 2025 vs 2032
 Figure 40. Japan Tumor Gene Test Service Sales Value by Application (%), 2025 vs 2032
 Figure 41. South Korea Tumor Gene Test Service Sales Value (US$ Million), 2021–2032
 Figure 42. South Korea Tumor Gene Test Service Sales Value by Type (%), 2025 vs 2032
 Figure 43. South Korea Tumor Gene Test Service Sales Value by Application (%), 2025 vs 2032
 Figure 44. Southeast Asia Tumor Gene Test Service Sales Value (US$ Million), 2021–2032
 Figure 45. Southeast Asia Tumor Gene Test Service Sales Value by Type (%), 2025 vs 2032
 Figure 46. Southeast Asia Tumor Gene Test Service Sales Value by Application (%), 2025 vs 2032
 Figure 47. India Tumor Gene Test Service Sales Value (US$ Million), 2021–2032
 Figure 48. India Tumor Gene Test Service Sales Value by Type (%), 2025 vs 2032
 Figure 49. India Tumor Gene Test Service Sales Value by Application (%), 2025 vs 2032
 Figure 50. Tumor Gene Test Service Value Chain
 Figure 51. Tumor Gene Test Service Cost Structure
 Figure 52. Channels of Distribution (Direct Sales, and Distribution)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed

お見積>

サンプルお申込み>

今すぐ購入>

PDFダウンロード>

当社から購入のメリット
  • jiantou

    多言語（英語、日本語）のサンプル提供

  • jiantou

    プロフェッショナルな日本語翻訳を提供

  • jiantou

    請求書、クレジットカードでのお支払いが可能です

  • jiantou

    必要なチャプターやカスタマイズされたレポートの注文が可能

  • jiantou

    購入後、アナリストに直接連絡することができます

購入方法
shunxu

  • 必要な言語とバージョンのレポート選択

  • レポート要件と見積もり依頼

  • 電子メールによる注文

  • レポートの入手（英語版は2～4営業日、日本語版は8～10営業日）

  • クレジットカード決済、オフライン振込に対応（後払い可）

※当サイトに掲載されていない海外調査報告書も当社経由でご購入いただけますので、お問い合わせください。

※市場調査レポートの購入や市場調査をご希望の場合は、実績と信頼のある株式会社市場調査センターにお任せください。

*フォーチュン500企業は当社と緊密な協力関係を確立しています

クライアント様（例）
ご利用ガイド
利用規約よくあるご質問プライバシーポリシー支払い方法と購入ガイド
お電話でのお問い合わせ
email050-5840-2692 日本
email0081-50-5840-2692 グローバル
9:00-18:00 (土日・祝日を除く)
底部logo
Copyright 2016-2026 Global Reports著作権所有